Ozempic Might Be Profitably Manufactured A lot Cheaper: Examine

Ozempic, the appetite-suppressing injection also referred to as semaglutide, at present prices $935.77 within the U.S. with out insurance coverage. However a new analysis report from Yale College, King’s School Hospital in London, and Medical doctors With out Borders printed in JAMA Community Open Wednesday means that the value of the prescription drug could possibly be lowered to a fraction of what it’s proper now, whereas nonetheless producing a revenue.

The researchers calculated cost-based costs for one month of Ozempic, administered as an injectable of 0.77 mg weekly, by combining industrial commerce cargo information from January 1, 2016 to March 31, 2023 with the price of creating the drug, different working bills, a revenue margin, and tax. They discovered that the cost-based costs of Ozempic ranged from $0.89 to $4.73 monthly.

“The findings of this research recommend that insulins, SGLT2Is, and GLP1As can doubtless be manufactured for costs far under present costs, enabling wider entry,” the researchers wrote.

A pharmacist holds a field of Novo Nordisk A/S Ozempic model semaglutide remedy. Photographer: George Frey/Bloomberg through Getty Photos

Ozempic prices much less outdoors of the U.S. — a Bloomberg report discovered {that a} month’s provide of the injectable prices below $300 in Mexico.

“Exterior the US, international locations have totally different regulatory necessities with regard to the pricing of medicines, together with negotiating with respective authorities entities,” Ozempic maker Novo Nordisk instructed Bloomberg.

Associated: FDA Has Seized ‘Hundreds’ of Faux Items of Ozempic Amid Reported Circumstances of ‘Opposed Reactions’ in Sufferers

Drug markups have lengthy come below nationwide scrutiny, with Martin Shkreli, the previous head of Turing Prescription drugs, pressured to pay $64 million in 2022 after inflating the value of a life-saving drug by 4,000%.

Ozempic falls below the class of a GLP-1 drug, which means that it addresses kind 2 diabetes by bettering blood sugar management and in addition doubtlessly resulting in weight reduction, in response to the Mayo Clinic.

Prescriptions of GLP-1 medication elevated by 300% between 2020 and 2022, Trilliant Well being researchers discovered. Ozempic first made headlines in 2021 when it was featured on the Dr. Oz Present.

Associated: Novo Nordisk, the Maker of Ozempic, Is Suing Spas and Clinics For Allegedly Promoting Knockoffs

Ozempic and different related medication might trigger a mean weight lack of 15% to twenty%, “considerably greater than earlier choices,” as per Columbia Surgical procedure.

The identical publication warns of the life-long dedication Ozempic requires, as discontinuing the drug might result in gaining all the weight again. The drug might additionally trigger nausea, cramps, and different disagreeable unintended effects.

Regardless of the excessive value and potential downsides, Ozempic skyrocketed in reputation final 12 months, with 66% of its greater than $13 billion gross sales coming from the US, in response to Novo Nordisk’s 2023 annual report.

Associated: Novo Nordisk Is Value Extra Than Denmark’s GDP Due to America’s Ozempic and Wegovy Craze

Leave a Reply

Your email address will not be published. Required fields are marked *